Edition:
United Kingdom

Axsome Therapeutics Inc (AXSM.OQ)

AXSM.OQ on NASDAQ Stock Exchange Global Market

3.01USD
14 Dec 2018
Change (% chg)

$-0.06 (-1.95%)
Prev Close
$3.07
Open
$3.01
Day's High
$3.10
Day's Low
$2.96
Volume
44,375
Avg. Vol
38,457
52-wk High
$5.90
52-wk Low
$2.05

Chart for

About

Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing therapies for the management of central nervous system (CNS) disorders, including pain. It operates in the business of developing novel therapies for the management of CNS disorders segment. Its product candidate, AXS-02... (more)

Overall

Beta: --
Market Cap(Mil.): $146.39
Shares Outstanding(Mil.): 23.61
Dividend: --
Yield (%): --

Financials

  AXSM.OQ Industry Sector
P/E (TTM): -- 69.71 34.39
EPS (TTM): -1.47 -- --
ROI: -90.07 9.01 14.96
ROE: -102.68 10.15 16.52

Earnings vs. Estimates